APGE Exercise Disclosure
Dambkowski Carl · SEC Form 4 · Filed Jul 2, 2026
Exercise
Calculated transaction value
$94.3K
Dambkowski Carl Chief Medical Officer
APGE
Apogee Therapeutics
APGE
Transaction date
Jul 1, 2026
Public filing date
Jul 3, 2026
Filing lag
Filed 2 days later
APGE daily price context
Close on/before transaction
$132.77
Jul 1, 2026
Close before public filing
$132.91
Jul 2, 2026
Return since public filing
+1.26%
Through Aug 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,125 shares @ $22.86
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-080477
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$824.37K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Apogee Therapeutics, Inc. APGE Current | Exercise | Jul 1, 2026 | $94.3K |
| Apogee Therapeutics, Inc. APGE | Sale | Jul 1, 2026 | $730.07K |
| Apogee Therapeutics, Inc. APGE | Exercise | Jul 1, 2026 | $0 |